Histopathology Services Market Report 2021
Report Code: KNJ848973 No. of Pages: 143 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Extract: The Histopathology Services market is said to witness a significant growth during the forecast years between 2021 and 2028. Histopathology is a branch of pathology that deals with the examination of biological tissues in order to determine the proximity of diseased cells/tissues. It entails the investigation of minute changes/variations in tissues caused by a few infections. Histopathology tests are performed in histopathology research centres or laboratories, where a pathologist identifies changes or variations from normal tissues caused by disease. One of the major factors driving the global histopathology services market is the alarming rise in the number of such fatal medical conditions. Report Scope in detail: This latest report edition of Histopathology Services market has been added to our huge database of detailed reports and this envisions to shape the future of all the related businesses. Our team of learned research analysts have studied in-depth and curated the report based on several aspects which include the overview of the market, driving forces, growth rate, market trends, market size, opportunities and challenges of the market; along with detailed competitive analysis on the regional as well as global level. The Histopathology Services market research report renders a thorough analysis of the market on a global aspect and aims on several market segmentation. This report also provides deeper perception into the latest trends of the market and pinpoints crucial product developments of the industry. Furthermore, the report collects numerous factors that have accredited to the growth of the market in the recent years. Market Dynamics: • Aside from an increase in the prevalence of such chronic conditions, an increase in health-care expenditure, an increase in the geriatric population, and an increase in the use and effectiveness of biomarkers for disease diagnosis all contribute to the growth of the global histopathology services market. • Furthermore, technological advancements have resulted in more sophisticated pathology methods and services. • This increases market demand. Disease diagnosis and treatment research and development is thriving, particularly in developed countries. • Growth in technologies related to histopathology diagnosis is expected to propel Asia Pacific emerging markets. Histopathology Services Market Segmentation: By Type of Examination • Breast Biopsy • Surgical Specimen • Renal Biopsy • Lung Biopsy • Pancreatic Biopsy • Gastrointestinal Biopsy • Testicular Biopsy • Skin Tissue Biopsy • Others By End User • Research Institutes • Diagnostic Laboratories & Reference Laboratories • Others Regional Coverage • North America o United States o Canada o Mexico • Europe o UK o Germany o France o Italy o Spain o Russia o Rest of Europe • Asia Pacific o China o India o Japan o Korea o Australia o Southeast Asia o Rest of Asia-Pacific • South America o Brazil o Argentina o Colombia o Rest of South America • Middle East & Africa o GCC o South Africa o Rest of Middle East & Africa Competitive Analysis: Eminent market players have been outlined in order to extract improved insights into the worldwide businesses. Our research reports offer all-inclusive information on various top most manufacturers that are operational across global regions. We provide company profiles which include detailed overview of the company, business information, business performance, crucial strategies implemented through the years. Few of the Key Players Covered in Our Report: • Laboratory Corporation of America Holdings • TPL Path Labs • Sonic Healthcare Limited • Acculabs Diagnostics UK Ltd • Targos • UNILABS • Cureline Global Translational CRO • Experimental Pathology Laboratories Inc (EPL) • Cellular Pathology Services • CHARLES RIVER LABORATORIES, INC. Impact of COVID19: The COVID19 pandemic crippled the global economy, it resulted in a worldwide lockdown and this has majorly impacted numerous industries. Our industry experts are working round-the-clock to identify, accumulate and in-time deliver market analysis due to the effect of unprecedented decisions in COVID-19 repercussions on many businesses. The full version of this report will comprise the overall impact of the pandemic, and predicted alteration on the future outlook of the industry, by taking into the account the economic, political, technological and social parameters.
Section 1: Executive Summary 1.1. Histopathology Services Market Industry 360° outline, Year 2016 – 2028 1.2. Business Model Trends 1.3. Growth Trends 1.4. End-User/End User Trends 1.5. Regional Trends Section 2: Market Dynamics - Histopathology Services Market Industry Insights 2.1. Growth Drivers 2.2. Opportunities 2.3. Industry challenges 2.4. SWOT Analysis 2.5. Porter’s Analysis 2.6. Worldwide Industry Landscape, Year 2016 – 2028 2.7. Industry Segmentation 2.8. Technology & Invention landscape 2.9. Regional Landscape 2.9.1. North America 2.9.2. Europe 2.9.3. Asia-Pacific 2.9.4. South America 2.9.5. Middle East & Africa 2.10. Competitive Environment Section 3: Global Histopathology Services Market, By Type of Examination 3.1. Segmentation Analysis, By Type of Examination, 2016-2028 3.2. Market Share Segmentation Analysis, By Type of Examination, 2016-2028 3.3. Breast Biopsy 3.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 3.4. Surgical Specimen 3.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 3.5. Renal Biopsy 3.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 3.6. Lung Biopsy 3.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 3.7. Pancreatic Biopsy 3.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 3.8. Gastrointestinal Biopsy 3.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 3.9. Testicular Biopsy 3.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 3.10. Skin Tissue Biopsy 3.10.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 3.11. Others 3.11.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 Section 4: Global Histopathology Services Market, By End User 4.1. Segmentation Analysis, By End User, 2016-2028 4.2. Market Share Segmentation Analysis, By End User, 2016-2028 4.3. Research Institutes 4.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 4.4. Diagnostic Laboratories & Reference Laboratories 4.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 4.5. Others 4.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 Section 5: Global Histopathology Services Market, Regional Analysis 5.1. Global Histopathology Services Market, Regional Analysis 5.2. North America, Country level Analysis 5.2.1. North America Histopathology Services Market estimates and forecast with Growth rate analysis, By Type of Examination, 2016 – 2028 5.2.2. North America Histopathology Services Market estimates and forecast with Growth rate analysis, By End User, 2016 – 2028 5.2.3. United States 5.2.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.2.4. Canada 5.2.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.2.5. Mexico 5.2.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.3. Europe Country level Analysis 5.3.1. Europe Histopathology Services Market estimates and forecast with Growth rate analysis, By Type of Examination, 2016 – 2028 5.3.2. Europe Histopathology Services Market estimates and forecast with Growth rate analysis, By End User, 2016 – 2028 5.3.3. UK 5.3.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.3.4. Germany 5.3.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.3.5. France 5.3.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.3.6. Italy 5.3.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.3.7. Spain 5.3.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.3.8. Russia 5.3.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.3.9. Rest of Europe 5.3.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.4. Asia-Pacific Country level Analysis 5.4.1. Asia-Pacific Histopathology Services Market estimates and forecast with Growth rate analysis, By Type of Examination, 2016 – 2028 5.4.2. Asia-Pacific Histopathology Services Market estimates and forecast with Growth rate analysis, By End User, 2016 – 2028 5.4.3. China 5.4.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.4.4. India 5.4.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.4.5. Japan 5.4.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.4.6. Korea 5.4.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.4.7. Australia 5.4.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.4.8. Southeast Asia 5.4.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.4.9. Rest of Asia-Pacific 5.4.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.5. South America Country level Analysis 5.5.1. South America Histopathology Services Market estimates and forecast with Growth rate analysis, By Type of Examination, 2016 – 2028 5.5.2. South America Histopathology Services Market estimates and forecast with Growth rate analysis, By End User, 2016 – 2028 5.5.3. Brazil 5.5.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.5.4. Argentina 5.5.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.5.5. Colombia 5.5.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.5.6. Rest of South America 5.5.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.6. Middle East & Africa Country level Analysis 5.6.1. MEA Histopathology Services Market estimates and forecast with Growth rate analysis, By Type of Examination, 2016 – 2028 5.6.2. MEA Histopathology Services Market estimates and forecast with Growth rate analysis, By End User, 2016 – 2028 5.6.3. GCC 5.6.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.6.4. South Africa 5.6.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.6.5. Rest of Middle East & Africa 5.6.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 Section 6: Company Profile - Histopathology Services Market 6.1. Laboratory Corporation of America Holdings 6.1.1. Business Overview 6.1.2. Product & Service Offering 6.1.3. Overall Revenue 6.1.4. Strategic Outlook 6.2. TPL Path Labs 6.2.1. Business Overview 6.2.2. Product & Service Offering 6.2.3. Overall Revenue 6.2.4. Strategic Outlook 6.3. Sonic Healthcare Limited 6.3.1. Business Overview 6.3.2. Product & Service Offering 6.3.3. Overall Revenue 6.3.4. Strategic Outlook 6.4. Acculabs Diagnostics UK Ltd 6.4.1. Business Overview 6.4.2. Product & Service Offering 6.4.3. Overall Revenue 6.4.4. Strategic Outlook 6.5. Targos 6.5.1. Business Overview 6.5.2. Product & Service Offering 6.5.3. Overall Revenue 6.5.4. Strategic Outlook 6.6. UNILABS 6.6.1. Business Overview 6.6.2. Product & Service Offering 6.6.3. Overall Revenue 6.6.4. Strategic Outlook 6.7. Cureline Global Translational CRO 6.7.1. Business Overview 6.7.2. Product & Service Offering 6.7.3. Overall Revenue 6.7.4. Strategic Outlook 6.8. Experimental Pathology Laboratories Inc (EPL) 6.8.1. Business Overview 6.8.2. Product & Service Offering 6.8.3. Overall Revenue 6.8.4. Strategic Outlook 6.9. Cellular Pathology Services 6.9.1. Business Overview 6.9.2. Product & Service Offering 6.9.3. Overall Revenue 6.9.4. Strategic Outlook 6.10. CHARLES RIVER LABORATORIES, INC. 6.10.1. Business Overview 6.10.2. Product & Service Offering 6.10.3. Overall Revenue 6.10.4. Strategic Outlook *Market size and forecast will be provided from 2016-2028, and forecast period would be 2021-2028 *Details on financial performance and strategic moves and developments may not be captured for unlisted companies *List of companies profiled in this TOC is tentative and may change after detailed analysis
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com